- Home
- SY vs FENC Comparison
SY vs FENC Comparison
Compare SY & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SY
- FENC
- Stock Information
- Founded
- SY 2013
- FENC 1996
- Country
- SY China
- FENC United States
- Employees
- SY N/A
- FENC N/A
- Industry
- SY EDP Services
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SY Technology
- FENC Health Care
- Exchange
- SY Nasdaq
- FENC Nasdaq
- Market Cap
- SY 289.0M
- FENC 234.9M
- IPO Year
- SY 2019
- FENC 2001
- Fundamental
- Price
- SY $3.52
- FENC $8.00
- Analyst Decision
- SY Strong Buy
- FENC Strong Buy
- Analyst Count
- SY 1
- FENC 2
- Target Price
- SY $5.50
- FENC $13.50
- AVG Volume (30 Days)
- SY 951.7K
- FENC 67.9K
- Earning Date
- SY 11-19-2025
- FENC 11-12-2025
- Dividend Yield
- SY 0.76%
- FENC N/A
- EPS Growth
- SY N/A
- FENC N/A
- EPS
- SY N/A
- FENC N/A
- Revenue
- SY $197,807,588.00
- FENC $33,302,000.00
- Revenue This Year
- SY $8.61
- FENC N/A
- Revenue Next Year
- SY $54.55
- FENC $64.79
- P/E Ratio
- SY N/A
- FENC N/A
- Revenue Growth
- SY N/A
- FENC N/A
- 52 Week Low
- SY $0.66
- FENC $3.96
- 52 Week High
- SY $6.28
- FENC $9.92
- Technical
- Relative Strength Index (RSI)
- SY 55.32
- FENC 37.06
- Support Level
- SY $2.81
- FENC $8.21
- Resistance Level
- SY $3.22
- FENC $9.16
- Average True Range (ATR)
- SY 0.22
- FENC 0.40
- MACD
- SY 0.06
- FENC -0.08
- Stochastic Oscillator
- SY 69.08
- FENC 12.12
About SY So-Young International Inc. American Depository Shares
So-Young International Inc is an online destination for discovering, evaluating, and reserving medical aesthetic services in China. Its business model comprises four integrated components: professional content and its distribution through social media networks and its targeted media platforms in China, a social community characterized by signature user-generated content, Online reservation services for a medical aesthetic treatment, and the research, development, production, sales and agency of laser and other optoelectronic medical beauty equipment. It generates revenue from information services fees and reservation services fees from medical aesthetic service providers.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.